Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.

China-Japan Friendship Hospital

Status: Enrolling

Conditions: Pulmonary Artery Sarcoma

Study type: Observational

Funder types: Other

Identifiers

NCT06165718

Roadmap for PAS-2022

Details and patient eligibility

About

This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

Full description

This is an observational study covering mainland China, and patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

Enrollment: 120 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Computed tomography pulmonary angiography indicated that there were intraluminal defects
• Malignant histopathology was sarcoma
• Informed consent form was signed

Exclusion criteria

• Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma
• Expected inability to complete follow-up